Cargando…
Mathematical Modeling and Mutational Analysis Reveal Optimal Therapy to Prevent Malignant Transformation in Grade II IDH-Mutant Gliomas
Isocitrate dehydrogenase-mutant low-grade gliomas (IDHmut-LGG) grow slowly but frequently undergo malignant transformation, which eventually leads to premature death. Chemotherapy and radiotherapy treatments prolong survival, but can also induce genetic (or epigenetic) alterations involved in transf...
Autores principales: | Aoki, Kosuke, Suzuki, Hiromichi, Yamamoto, Takashi, Yamamoto, Kimiyo N., Maeda, Sachi, Okuno, Yusuke, Ranjit, Melissa, Motomura, Kazuya, Ohka, Fumiharu, Tanahashi, Kuniaki, Hirano, Masaki, Nishikawa, Tomohide, Shimizu, Hiroyuki, Kitano, Yotaro, Yamaguchi, Junya, Yamazaki, Shintaro, Nakamura, Hideo, Takahashi, Masamichi, Narita, Yoshitaka, Nakada, Mitsutoshi, Deguchi, Shoichi, Mizoguchi, Masahiro, Momii, Yasutomo, Muragaki, Yoshihiro, Abe, Tatsuya, Akimoto, Jiro, Wakabayashi, Toshihiko, Saito, Ryuta, Ogawa, Seishi, Haeno, Hiroshi, Natsume, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635454/ https://www.ncbi.nlm.nih.gov/pubmed/34333454 http://dx.doi.org/10.1158/0008-5472.CAN-21-0985 |
Ejemplares similares
-
Survival Benefit of Supratotal Resection in a Long-term Survivor of IDH-wildtype Glioblastoma: A Case Report and Literature Review
por: YAMAGUCHI, Junya, et al.
Publicado: (2021) -
Multiple metastases to the bone and bone marrow from a 1p/19q-codeleted and IDH2-mutant anaplastic oligodendroglioma: a case report and literature review
por: Shimizu, Hiroyuki, et al.
Publicado: (2020) -
TB-03 Newly Established Meningioma Organoid Model Elucidated an Important Role of FOXM1 in Meningioma Progression
por: Yamazaki, Shintaro, et al.
Publicado: (2020) -
Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series
por: Kibe, Yuji, et al.
Publicado: (2023) -
Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma
por: Adilijiang, Alimu, et al.
Publicado: (2019)